Germinal centers (GCs) are sites of intense B cell proliferation and are central for T cell-dependent antibody responses. However, the role of c-Myc, a key cell-cycle regulator, in this process has been questioned. Here we identified c-Myc + B cell subpopulations in immature and mature GCs and found, by genetic ablation of Myc, that they had indispensable roles in the formation and maintenance of GCs. The identification of these functionally critical cellular subsets has implications for human B cell lymphomagenesis, which originates mostly from GC B cells and frequently involves MYC chromosomal translocations. As these translocations are generally dependent on transcription of the recombining partner loci, the c-Myc + GC subpopulations may be at a particularly high risk for malignant transformation. npg
A r t i c l e s
In response to T cell-dependent antigens, antigen-specific B cells are driven into the germinal center (GC) reaction, which is critical for the generation and selection of memory B cells and plasma cells that express somatically mutated high-affinity antibodies 1 . GCs are sites of massive B cell proliferation 2 . However, despite extensive research on the GC reaction, the mechanisms that drive GC B cell proliferation have remained elusive. An issue of particular importance is the proposal that c-Myc, a master regulator of cellular proliferation in both nonhematopoietic and hematopoietic cells, including B cells 3, 4 , does not have a role in this process 5, 6 .
The transcription factor c-Myc was first identified as the cellular homolog of the transforming determinant carried by the avian myelocytomatosis virus MC29 (ref. 7) . The conservation of cellular homologs of viral oncogenes across evolutionary time and species suggests important roles for the products of these genes in normal cellular physiology 7 . Indeed, germline ablation of Myc leads to early embryonic death (at embryonic days 9-10) due to widespread failure in organ and tissue growth 8 . In the hematopoietic compartment, c-Myc is required at early developmental stages of B cells and T cells in the bone marrow and thymus, respectively 4, 9 . Experimental evidence has demonstrated that c-Myc has a crucial role in regulating the proliferation, apoptosis and differentiation of mammalian cells in general 8 . During progression through the cell cycle, c-Myc promotes the transition from G0-G1 to S phase through the activation of genes encoding proteins of the cyclindependent kinase (CDK) complex, including cyclin D2 (Ccnd2), as well as by the repression of CDK inhibitors 10, 11 .
Although early studies suggested considerable abundance of c-Myc transcripts and protein in human and mouse GC B cells [12] [13] [14] , subsequent work has refuted those observations and has found only low c-Myc expression in those cells 5, 6 . According to those studies, the expression of c-Myc in GC B cells is similar to or even lower than that observed in quiescent follicular (FO) B cells, in which c-Myc does not seem to have a major function 3 , which suggests a dispensable role for c-Myc in GC B cell proliferation. Further support for that hypothesis has been provided by the observation that Bcl-6, a master regulator of the development of GC B cells 15 , interacts with the transcription factor MIZ1 (ZBTB17), a known partner of c-Myc, to suppress CDK inhibitors 16 , and that Bcl-6 itself can repress transcription of the gene encoding c-Myc 17 . Moreover, in line with the ability of Bcl-6 to inhibit Ccnd2 expression 17 , among the CDK proteins, GC B cells express mainly cyclin D3 (Ccnd3), which, although dispensable for GC initiation 18, 19 , is required for GC maturation and is not controlled by c-Myc 10, 11 .
Most human B cell lymphomas originate from GC or post-GC B cells, as demonstrated by their somatically mutated immunoglobulin genes [20] [21] [22] . In the GC microenvironment, rapidly dividing B cells undergo somatic hypermutation and class-switch recombination of their immunoglobulin genes; both of these processes involve DNA strand breaks 22 . Infidelity in these processes increases the probability of oncogenic events such as chromosomal rearrangements 22 . The MYC gene itself is frequently involved in chromosomal translocations in human GC-derived B cell lymphomas 22 . Such translocations, found in ~10% of diffuse large B cell lymphomas and almost all cases of sporadic Burkitt lymphoma, juxtapose MYC and enhancers in the immunoglobulin loci, which leads to deregulated MYC expression 22 . However, evidence supports the proposal that the introduction of somatic mutations by the cytidine deaminase enzyme AID, responsible for both somatic hypermutation and class-switch recombination, depends on gene transcription 23, 24 . Thus, there is an apparent contradiction between the absence of MYC transcription in GC B cells and the recurrent MYC translocations observed in the human lymphomas originating from these cells. A likely hypothesis is that the association of deregulated expression of MYC with GC B cell lymphomagenesis reflects the role of c-Myc in the regulation of cell proliferation at some stage of the GC reaction. Here, by genetic experiments with mice, we found that c-Myc was expressed in subsets of GC B cells in both immature and mature GCs and that these cells had an essential role in the formation and maintenance of GCs.
RESULTS

Target-gene expression suggests c-Myc activity
Conflicting results have been obtained for c-Myc expression in FO and GC B cells 5, 6, [12] [13] [14] . We re-evaluated this issue by analyzing gene expression by quantitative PCR in splenic FO and GC B cells that were derived from wild-type mice immunized with sheep red blood cells (SRBCs) and then purified by flow cytometry (Fig. 1a) . First we compared the expression of genes expressed mainly in GC B cells rather than FO B cells, which provided an internal control for our sorting strategy. Consistent with published findings 15, 22 , expression of both Aicda (which encodes AID) and Bcl6 was significantly higher in GC B cells than in FO B cells ( Fig. 1b) . In contrast, Myc expression was identical in GC and FO B cells ( Fig. 1c ), in agreement with published studies and in support of the hypothesis that c-Myc is dispensable in GC B cells 5, 6 . However, Myc mRNA is highly unstable 25 , therefore transcript abundance might not correlate with protein activity 25 . For that reason we did gene-set enrichment analysis (GSEA) 26 of published gene-expression profiles of FO and GC B cells 27 , evaluating c-Myc activity through the expression of its target genes. Using a list of c-Myc target genes derived from mouse B cells 28 , we observed highly significant enrichment for the expression of c-Myc-induced genes in GC B cells, whereas the converse was true for genes downregulated by c-Myc (Fig. 1d) . These observations remained significant when we removed genes associated with the gene-ontology terms 'proliferation' , 'cell cycle' and 'growth function' from the analysis (Fig. 1e) . We obtained similar results for lists of genes with c-Mycbinding motifs in their promoters and for a set of genes upregulated by c-Myc in (GC B cell-derived) Burkitt lymphoma lines 29 (Supplementary Fig. 1 ). Thus, although on average GC B cells did not have higher expression of Myc mRNA than did FO B cells, 
Some immature and mature GC B cells express c-Myc
To address whether c-Myc activity is restricted to just subsets of GC B cells, we used a Myc reporter allele 30 in which a fusion protein of c-Myc and enhanced green fluorescent protein (c-Myc-eGFP) is expressed from the endogenous Myc locus (Myc-eGFP). By flow cytometry we observed the appearance of c-Myc + GC B cells early after immunization of mice with SRBCs; this reached roughly 20% of GC B cells by day 4 ( Fig. 2a,b) , an early time point of GC development before the onset of substantial population expansion of GC B cells ( Supplementary  Fig. 2) . We also observed a c-Myc + population of GC B cells (~10%) at day 10 after immunization, a time point that reflects the peak of the GC reaction ( Fig. 2b and Supplementary Fig. 2 ). Small subsets of non-GC B cells, but not of plasma cells, with low expression of c-Myc protein were also present in the immunized mice ( Supplementary Fig. 3 and data not shown). Using the Myc-eGFP reporter allele and GC B cell markers, we purified the c-Myc + GC B cells as well as their c-Myc − counterparts by flow cytometry on day 4 and day 10 after immunization and analyzed gene expression by quantitative PCR. The c-Myc + GC B cells isolated on day 10 had higher expression of Myc than did FO B cells, whereas this was not the case for the c-Myc + GC B cells on day 4 after immunization ( Fig. 2c) . However, c-Myc + GC B cells at day 4 had a greater abundance of c-Myc-eGFP than did their counterparts at day 10 ( Supplementary Fig. 3 ), which probably reflected the effect of post-transcriptional control on c-Myc protein 8 . Further analysis showed that c-Myc + GC B cells at day 4 had ~70% lower expression of of Bcl6 mRNA 15 than did FO B cells ( Fig. 2d) , whereas the expression of other GC B cell genes, such as Mybl1 (which encodes A-Myb) 31 and Aicda 22 , was much higher in the former cells than in the latter cells (~20-fold and 50-fold, respectively; Fig. 2d ). There was also a greater abundance of somatic mutations in gene rearrangements of the immunoglobulin heavy-chain (Igh) variable region in c-Myc + GC B cells at day 4 than in FO B cells ( Fig. 2e) . The load of somatic mutations and the fraction of cells carrying these mutations in their Igh variable region was further increased in c-Myc − GC B cells at day 4 as well as in both c-Myc + and c-Myc − GC B cells at day 10 after immunization ( Fig. 2e ). In addition, those GC B cell subpopulations had much higher expression of Bcl6, Mybl1 and Aicda than did FO B cells or c-Myc + GC B cells at day 4 ( Fig. 2d,e ). Hence, through the use of a Myc-eGFP reporter allele that allows the visualization of c-Myc protein in single cells, we identified distinct subpopulations of c-Myc + and c-Myc − B cells in both immature and mature GCs.
Early GC B cells express c-Myc and Bcl-6
After B cell area (~4 d after initial antigen encounter), where they undergo massive population expansion in the environment of follicular dendritic cells (FDCs) and form clusters of proliferating GC B cells 33 . Bcl-6 is an essential transcription factor for the formation of GC B cells 15 and is already required at the stage at which B cells migrate back into the intrafollicular B cell area 34 . Given the finding that early in the GC response, c-Myc + GC B cells had lower expression of the GC B cell genes Bcl6, Mybl1 and Aicda and fewer somatic mutations than did their c-Myc − counterparts (Fig. 2d,e) , we considered the possibility that those early c-Myc + GC B cells represented precursors of c-Myc − GC B cells. By immunofluorescence histology of spleens obtained from mice 4 d after immunization with SRBCs, we found that at the very initial stages of GC B cell cluster formation (≤20 cells), the cells in the clusters were both c-Myc + and Bcl-6 + ( Fig. 3a and Supplementary Fig. 4a) , and that as the number of GC B cells in the cluster increased (>20 cells), B cells gradually lost c-Myc expression (Fig. 3b,c and Supplementary Fig. 4b) .
WT (D4 SRBCi)
Although both c-Myc + and c-Myc − GC B cells expressed the typical GC B cell gene Ccnd3 (refs. 18,19; Fig. 3d ), the c-Myc + cells also expressed Ccnd2, a direct target of c-Myc 10,11 (Fig. 3e) . Both Ccnd2 and Ccnd3 encode known positive regulators of the cell-cycle transition from G0-G1 to S phase in B cells 10, 11, 18, 19 . Consistent with that, we found that more than 40% of the c-Myc + GC B cells were in S phase, compared with ~20% of c-Myc − GC B cells ( Fig. 3f,g) . Together these results suggested that early GC B cells were both c-Myc + and Bcl-6 + , had hyperproliferative properties and gave rise to GC B cells that were only Bcl-6 + .
GC formation requires c-Myc
To determine whether c-Myc was critical for GC formation, we deleted Myc from GC B cells through the use of mice carrying alleles for conditional ablation of c-Myc, with GC B cell-specific expression of Cre recombinase (via a transgene that expresses Cre from the gene encoding immunoglobulin γ-chain constant region 1 (Cγ1-Cre)) and a Cre-dependent human CD2 reporter ( Supplementary  Fig. 5 ) at an early stage of the GC reaction 3, 35, 36 . This resulted in almost complete ablation of GCs in response to T cell-dependent immunization (Fig. 4a, left) . Analysis of expression of the human CD2 reporter in the few remaining GC B cells present in mice with such GC ablation showed that these cells had largely escaped Cre-mediated recombination (Fig. 4a, right) . We further confirmed the impairment of GC B cell formation after the ablation of Myc by analyzing additional GC B cell markers by histology and immunohistochemistry ( Fig. 4b) . Ablation of Myc in GC B cells interfered with the GC reaction from early after immunization of mice with SRBCs, consistent with the observed expression of c-Myc at the initiation of the GC response ( Fig. 4c) . It also prevented B cells from participating in GC responses in Peyer's patches in the absence of intentional immunization, as was evident from the considerable counterselection of GC B cells expressing the human CD2 reporter in Peyer's patch GCs, in which the transgene encoding Cre induces Cre-mediated recombination in approximately 30-40% of the GC B cells in control mice (mice carrying the human CD2 reporter together with the Cγ1-Cre transgene) 35 (Fig. 4d) . We concluded that c-Myc had an essential role in both induced and spontaneous GC formation.
Bcl-6 does not restore GC formation after Myc ablation It has been proposed that Bcl-6 has a role in GC B cell proliferation through transcriptional repression of CDK inhibitors by interaction with MIZ1, a known partner of c-Myc 16 . We therefore decided to test whether prematurely enhanced Bcl6 expression would restore the formation of GCs after ablation of Myc. To address this issue, we ectopically expressed Bcl6 with an allele in which mouse Bcl6 cDNA is inserted downstream of the Iµ promoter in the Igh locus, which leads to transgenic Bcl6 expression from early stages of B cell development onward 37 . Although expression of Bcl6 from this allele has been shown to be sufficient to restore the differentiation of GC B cells in the spleens of Bcl6-deficient mice 37 , it did not restore GC formation after conditional ablation of Myc ( Fig. 5a and Supplementary Fig. 6a) .
Similarly, in Peyer's patches from the mice described above with conditional ablation of Myc from GC B cells (Fig. 4a) , ectopic Bcl6 expression was unable to restore spontaneous GC formation (Supplementary Fig. 6b,c) . The deficiency in induced and spontaneous GC formation after Myc ablation was also not 'rescued' by ectopic Bcl2 expression 38 (Supplementary Fig. 6a,b,d,e) , which emphasized A r t i c l e s the essential role of c-Myc in the development of GC B cells. In contrast, concomitant ablation of the endogenous Myc gene and enforced expression of MYC from the ubiquitous Rosa26 allele was able to fully restore GC formation (Fig. 5b,c and Supplementary Figs. 5 and 6a,b) as well as production of IgG1 ( Fig. 5d and Supplementary Fig. 6f) .
These results demonstrated a nonredundant role for c-Myc in the initiation of GC formation.
Mature c-Myc + GC B cells localize to the light zone
Early histological observations by light microscopy suggested the compartmentalization of mature GCs in two morphologically distinct areas: a dark zone (DZ) adjacent to the T cell zone, and a light zone (LZ) contiguous to the splenic marginal zone or to the lymph node capsule 39 . The lighter and darker appearances of the GC LZ and DZ, respectively, result from the fact that B cells in the LZ are scattered among a network of FDCs that are largely absent from the DZ 2 . In an attempt to better characterize the population of mature c-Myc + GC B cells, we used antibodies to stain markers that allow the discrimination of B cells in the DZ and LZ of the GC 2,40 . By flow cytometry we found that more c-Myc + GC B cells had lower expression of CXCR4 and higher expression of CD83 than did their c-Myc − counterparts (Fig. 6a) . In agreement with that, we found npg by histology and immunofluorescence microscopy that c-Myc + GC B cells were interspersed among FDCs (Fig. 6b,c and Supplementary  Fig. 7a-c) . Those observations led us to conclude that most of the c-Myc + GC B cells in mature GCs localized to the LZ. Consistent with the proposal that in the LZ, a small fraction of GC B cells undergo T cell-mediated activation 40 , the c-Myc + mature GC B cells had a phenotype characteristic of recently activated lymphocytes. This phenotype included higher surface expression of the activation markers CD86, CD83, CD40, CD69 and major histocompatibility complex class II (Fig. 6d,e and Supplementary Fig. 7d ) and higher expression of the immediate-early genes Nfkbia (which encodes the transcription factor NF-κB inhibitor IκBα; IκBα expression is indicative of NF-κB activity) and Myc itself ( Figs. 6f and 2c) . Consistent with enhanced NF-κB activity 41 , expression of Irf4 (which encodes the transcription factor IRF4) was also higher in c-Myc + GC B cells (Fig. 6g) , whereas Bcl6 was downregulated (Fig. 2d) . That was in agreement with the proposal that CD40 activation signals delivered to B cells by T cells in the LZ direct them to class switching 42 and inhibit Bcl6 expression 43 . Analysis of the expression of c-Myc target genes also suggested more c-Myc transcriptional activity in the c-Myc + GC B cells than in their c-Myc − counterparts ( Fig. 6h and Supplementary Fig. 7e) . Thus, c-Myc + GC B cells in mature GCs localized mainly to the LZ and had an activated phenotype.
GC maintenance requires c-Myc + GC B cells
As a key function of c-Myc is to promote the transition from G0-G1 to S phase 10,11 , we assessed whether mature c-Myc + GC B cells had a proliferative phenotype. Indeed, we found higher expression of Ccnd2 and Ccnd3 in those cells than in FO B cells (Fig. 7a) . In contrast, c-Myc − GC B cells had higher expression of Ccnd3 alone (Fig. 7a) . DNA labeling and flow cytometry demonstrated that a considerable fraction (~38%) of the c-Myc + GC B cells were in the S phase of the cell cycle, whereas this was true for only ~20% of their c-Myc − counterparts (Fig. 7b,c) . Given the proliferative phenotype of c-Myc + GC B cells in mature GCs, we assessed whether c-Myc also had an essential role in GC maintenance. For this we devised an experimental celltransfer system that allowed us to conditionally ablate Myc in mature GC B cells. We used mice deficient in the B cell antigen receptorcoreceptor CD19, in which GC B cells do not develop 44 , as recipients of mature B cells. We derived donor cells from mice with a reporter 45 . After cell transplantation, we immunized the recipient mice with SRBCs and subsequently treated them with poly(I:C) at the peak of GC B cell formation to achieve Cre-mediated recombination in the progeny of the transferred B cells (Online Methods).
We observed a robust GC response after immunization and detected Cre-mediated recombination in 40-50% of mature GC B cells derived from B cells of mice without ablation of Myc (mice carrying the human CD2 reporter together with the Mx1-Cre transgene), as measured by surface expression of human CD2 (Fig. 7d, top) . In contrast, the total fraction of GC B cells was ~50% lower when the donor cells were derived from mice with conditional ablation of Myc, and only ~3% of the GC B cells were positive for human CD2 (Fig. 7d, bottom) . These results indicated massive counterselection of c-Myc-deficient mature GC B cells and suggested that Myc expression in mature GC B cells was required for the perpetuation of the GC reaction. We concluded that mature GC B cells went through a stage in the LZ at which c-Myc was essential for their maintenance and that of the GC.
DISCUSSION
In the present work we have re-evaluated the role of the transcription factor c-Myc, a master regulator of cellular proliferation, in the physiology of GC B cells. This unresolved problem derives from the conflicting observations that GC B cells have one of the fastest rates of cell division known in mammals 2 , whereas the expression of Myc in these cells is similar to that of quiescent FO B cells 3,5,6 . We found that although the analysis of bulk GC B cells did not show higher expression of Myc in those cells than in FO B cells, analysis of c-Myc protein at the single-cell level showed the presence of hyperproliferative c-Myc + subpopulations of GC B cells in both immature and mature GCs that were essential for the formation and maintenance of GCs. Using a conditional knockout approach, we found that ablation of Myc at an early stage of GC B cell development led to a complete absence of GC formation. Furthermore, c-Myc protein was expressed at the initiation of GC B cell cluster formation, which preceded the phase of massive GC B cell population expansion in the intrafollicular B cell area. At this stage we did not detect higher Myc expression than in FO B cells. This discrepancy probably reflected mechanisms of post-transcriptional control of c-Myc protein 8 and the fact that enhanced Myc transcription is an early transitory event that peaks at ~2 h after the activation of B cells, preceding the increase in RNA synthesis and DNA replication 25 . Repression by Bcl-6 may further restrain Myc transcription 17, 46 . This may be desirable, because AID, which is essential in GC B cells for diversification of the antibody repertoire, can target transcriptionally active genes outside the immunoglobulin loci [22] [23] [24] and promote the translocation of such genes 24 .
In mature GCs, however, we identified another subset of GC B cells that had a greater abundance of c-Myc transcripts than that of FO B cells and localized predominantly to the LZ. Identical observations have been made for human GCs 46 . The mature c-Myc + GC B cells showed features of cellular activation and may have represented the fraction of GC B cells in the LZ undergoing T cell-mediated activation to re-enter the DZ. In agreement with that, we detected in c-Myc + mature GC B cells activation of the NF-κB pathway and higher expression of target genes of this pathway-that is, Myc 47 itself and Irf4 (ref. 42)-but downregulation of Bcl6 (ref. 43 ). In addition, the hyperproliferative phenotype of the c-Myc + mature GC B cells, of which many were at the G2-M stage of the cell cycle, which is known to largely segregate to DZ GC B cells 40 , together with the strong effect of acute Myc ablation on the total fraction of GC B cells, suggested that mature c-Myc + GC B cells were poised for re-entry into the DZ and perpetuation of the GC reaction, an idea further supported by a related report published in this issue 46 .
The transcription factor Bcl-6 is essential for the development of GC B cells 15 . Detailed examination of the relationship between Bcl-6 and cellular proliferation led to the hypothesis that GC B cells have an alternative, c-Myc-independent cell cycle program 16 . Along those lines, Bcl-6 interacts with the transcription factor MIZ1, a c-Myc partner, to suppress CDK inhibitors, and Myc transcription is repressed by Bcl-6 (refs. 16, 17, 48) . In addition, Bcl-6 inhibits the expression of Ccnd2 (ref. 17) , a c-Myc target, and Ccnd3, which is not controlled by c-Myc 10,11 , has prominent expression in GC B cells 18, 19 . Our studies have shown that at early stages of GC formation, c-Myc + GC B cells expressed both Ccnd2 and Ccnd3, which possibly contributed to their hyperproliferative phenotype, and we observed a similar pattern of expression of those genes in mature GC B cells when they upregulated c-Myc. The cyclic dependence of GC B cell proliferation on c-Myc activity probably reflects the process of 'cyclic re-entry' , in which stepwise antibody affinity maturation takes place through multiple rounds of selection 40, 49 . In this setting, the function of c-Myc in the GC reaction may be to induce competence 25 for GC B cell division to occur; that is, to 'decide' whether a GC B cell enters a phase of proliferative expansion.
Our work has implications for the understanding of the pathogenesis of human GC B cell-derived lymphomas with chromosomal translocations of MYC, seen in almost all sporadic Burkitt lymphomas and ~10% of diffuse large B cell lymphomas 22 . B cell lymphomas, the most common type of human lymphoid malignancies overall, originate mainly from either GC B cells or B cells that have passed through the GC reaction 22 . In the GC microenvironment, AID, the enzyme responsible for both somatic hypermutation and class-switch recombination, participates in the formation of chromosomal breaks in the MYC locus that lead to translocations of MYC and immunoglobulin genes, and MYC transcription is required for this process 23, 24 . The c-Myc + GC B cell subsets we have identified in mice and that also exist in humans 46 may therefore be prone to undergo translocation of the gene encoding c-Myc and represent a stage of GC B cell differentiation with a particularly high risk for malignant transformation.
METHODS
Methods and any associated references are available in the online version of the paper. Accession codes. GEO: microarray data, GSE39443.
Note: Supplementary information is available in the online version of the paper.
